Strategic partnerships Ayana Bio has established collaborations with Ginkgo Bioworks and Brevel, signaling a strong channel for co-developed bioactive ingredients using plant cell cultures and scalable fermentation. This presents opportunities to position joint value propositions to food, beverage, supplements, and cosmetics manufacturers seeking reliable, scalable plant-derived actives.

Scaled production potential The integration with Brevel’s illuminated fermentation platform and Ayana Bio's plant cell cultivation enables predictable, indoor manufacturing of high-value botanicals. Sales conversations can emphasize consistent supply, quality control, and reduced exposure to agricultural variability for customers with large-volume needs.

Growing market presence With recent press on grants and spin-off status from Ginkgo Bioworks, Ayana Bio is gaining visibility in biotech-enabled wellness ingredients. This momentum can be leveraged to approach brands seeking innovative, sustainably sourced bioactives and to explore co-branding or exclusive supply arrangements.

Diverse customer sectors Ayana Bio targets multiple end markets including food and beverages, dietary supplements, sports nutrition, animal care, and cosmetics. This breadth allows cross-market expansion opportunities and the tailoring of value propositions to different product claims such as standardized potency, safety, and sustainability.

Sustainability and quality focus The emphasis on standardized, safe, sustainably sourced bioactives and the use of plant cell culture aligns with consumer demand for transparency and consistent potency. Sales efforts can target brands prioritizing clean label, traceable ingredients, and dependable supply chains to reduce disruption risks.